NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.




By Irish Pharmacist - 28th Feb 2022


Late last year, the Healthy Ireland Survey 2021 reported that 18 per cent of Irish adults currently smoke; 16 per cent smoke daily; and 2 per cent smoke occasionally.

It is estimated that 6,000 deaths per year in Ireland in recent years were attributed to smoking (one-in-five of all deaths). In 2016, there were an estimated 55,000 hospital episodes (day case and inpatient) in publicly-funded hospitals attributable to smoking and exposure to second-hand smoke.

Last month, the national clinical effectiveness committee released a guideline to help healthcare professionals assist adults to stop smoking. 

This new guideline was developed by a multidisciplinary guideline development group led by the HSE Tobacco Free Ireland Programme and chaired by Dr Paul Kavanagh, Specialist in Public Health Medicine. 

“These new national clinical guidelines describe the evidence-based best practice for healthcare professionals providing people help to stop smoking… we look forward to working with healthcare professionals and the public to implement these guidelines in day-to-day practice across the health services and working with them towards a tobacco-free Ireland,” outlined Dr Kavanagh. 

I would say we do need to remain very alert, because those benefits have been very hard-won and they are very precious from a public health perspective 

The drop in smoking levels in recent decades is widely regarded as a significant public health gain. Dr Kavanagh explained that “we’re very proud of the huge progress we have made around controlling the amount of tobacco use in the population”. 

He pointed to statistics which showed that, two decades ago, smoking prevalence was as high as one-in-three in the population. 

Dr Kavanagh added Ireland had witnessed the implementation of a “really ambitious, high impact programme of policy intervention”, such as the bans on smoking in public and workplaces and the plain packaging reforms. 


However, he said recent figures indicate that the reduction in smoking levels may have “stalled”. 

“I would say we do need to remain very alert, because those benefits have been very hard-won and they are very precious from a public health perspective,” he said. 

Dr Kavanagh warned that there should be no “risk of complacency”. 

“While acknowledging the huge hard work and progress that has been made, I would urge 

I would say we do need to remain very alert, because those benefits have been very hard-won and they are very precious from a public health perspective 

 caution that we need to stay on this issue. The progress that has been made could slip.” 

To that end, Dr Kavanagh said the Government should review its Tobacco Free Ireland policy and then “pull together a very concrete and deliverable plan towards a tobacco-free Ireland”. 

Tobacco Free Ireland was launched in October 2013. The headline target was that Ireland would have a “smoking prevalence rate of less than 5 per cent by 2025, effectively making the country a tobacco-free society”. 

Dr Kavanagh said the “reality” was that goal was “looking increasingly unrealistic”. 

He praised the “very bold and ambitious goal that Government set for itself in 2013”, but added that there should be an interim “review” of that policy and goal. 

“Now, at the same time, I would say that shouldn’t be a reason for despondency or that we should back out of that goal,” added Dr Kavanagh, who said the 5 per cent goal should remain, but the timeline should be reviewed. 

“Our advice to the Department of Health and the Minister for Health would be that it is very timely, given where we are with Covid and given the findings of the most recent Healthy Ireland Survey to have an interim review of that goal. I’m not for a moment saying it is the wrong goal to have,” he said. 

 “We need to match that goal and the ambition of that goal with a bold programme of end-game planning where we systematically identify the steps that we are going to take over a period of time over a number of the [coming] years to achieve that goal.” 


Dr Kavanagh’s concern over a possible stalling in the reduction in tobacco prevalence in the population is based on the Healthy Ireland Survey figure of 18 per cent from last year, which was 1 per cent more than the figure in 2019. 

He noted that the “apparent” stalling “could be a blip in the statistics” from the recent survey. However, Dr Kavanagh added that the Central Statistics Office and international statistics showed that Covid-19 had impacted the smoking behaviour across the population “in a way that has probably been very mixed”. 

While some people have quit, others have relapsed due to the added stress and disruption to their lives in the pandemic. 

He also noted that stop smoking services had been impacted, like all non-Covid services in the health system. Particularly in 2021, “there was a downturn of the people who accessed our phone support, certainly our face-to-face support, were affected… as well”. However, services are now available again. 

With the fall in the number of people who smoke, there is the “concept of diminishing returns at the margins”, stated Dr Kavanagh. 

“The effort of imagination that was required to reduce smoking prevalence across the population from what it was over 20 years ago when it was one-in-three people — to get it down to 18 per cent, I think we will require a multiple of that imagination and effort to bring smoking down to 10 per cent, never mind bring it down to the 2025 [target of] 5 per cent,” Dr Kavanagh said. 

Due to the general focus on Covid, there is a risk “that people might think that tobacco control is ‘done and dusted’. I think there is clearly an imperative that we continue to progress.” 

On the new guidelines, Dr Kavanagh said they “have a very wide application” across healthcare. But he agreed that primary care and GPs in particular “can play a really powerful role in working with people who smoke”. Work has already commenced with the ICGP on the issue. 


Smoking is the “leading preventable cause of disease, disability and premature death in Ireland,” according to Dr Paul Kavanagh, Specialist in Public Health Medicine. 

“Yet there are three simple but powerful steps which every healthcare professional can take to maximise the chance that someone who smokes can successfully stop — asking about smoking; offering advice to stop; and providing practical support through arranging referral to a stop-smoking advisor and stop-smoking medicines.” 

The guidelines also advise that for people “who are currently interested in quitting, all healthcare professionals should recommend that behavioural support, either alone or in combination with pharmacological supports, increases the chances of successful quitting”. 

Healthcare professionals should recommend “varenicline (alone or in combination with nicotine replacement therapy (NRT)) as first-line treatment in the absence of a contraindication for those wishing to use pharmacological support. The guidelines further note that if varenicline is not suitable, combination NRT treatment should be recommended. 

There are further recommendations on aspects dealing with pregnancy and mental health facilities. 

E-cigarettes are mentioned in the guidelines, but they are not part of the recommendations. The guidelines note that they are “consumer products”. 

“There is some regulation in place to protect consumers of e-cigarettes, but not the same quality and safety system as would be in place for a licensed drug or medical device,” according to the document. 

Dr Kavanagh explained that in other jurisdictions, such as the UK, medicine regulators are “increasingly interested in taking on a role in regulation of e-cigarettes”. 

If the Health Products Regulatory Authority was to regulate e-cigarettes in the future, the considerations of the group may be different. 

Currently, according to Dr Kavanagh, there is “a lot of ambiguity in the area” of e-cigarettes. 

“It is evolving, it is very contested, and I think it’s fair to acknowledge even across the tobacco control community in Ireland and internationally there are people who have different views on this… so this was one of the more challenging areas we had to address.” 

He said that the evidence from studies on e-cigarettes was mixed. “We had to step back and look at the situation. Here we are with a toolkit that is already full of safe, effective, tried and tested stop-smoking supports… [but with e-cigarettes] we have all these questions and all these concerns. 

“From our perspective, it was very hard to see how you would take a risk on something that wasn’t proven, tried and tested, when actually you have a whole set of interventions that are very tried and tested.” 

*A summary and the full guidelines can be found at publication/4828b-stop-smoking/ 






Latest Issue

Irish Pharmacist July 2024

Irish Pharmacist July 2024

Irish Pharmacist July 2024. Volume 25 | Issue 7 | July 2024. Read the latest issue of Irish Pharmacist here…


OTC Update Spring 2024

Spring 2024 | Issue 1 | Volume 18. Read the latest issue of OTC Update here.